David Ketteridge

2.0k total citations
31 papers, 1.1k citations indexed

About

David Ketteridge is a scholar working on Physiology, Epidemiology and Rheumatology. According to data from OpenAlex, David Ketteridge has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Physiology, 13 papers in Epidemiology and 12 papers in Rheumatology. Recurrent topics in David Ketteridge's work include Lysosomal Storage Disorders Research (18 papers), Trypanosoma species research and implications (13 papers) and Glycogen Storage Diseases and Myoclonus (8 papers). David Ketteridge is often cited by papers focused on Lysosomal Storage Disorders Research (18 papers), Trypanosoma species research and implications (13 papers) and Glycogen Storage Diseases and Myoclonus (8 papers). David Ketteridge collaborates with scholars based in Australia, United States and United Kingdom. David Ketteridge's co-authors include Paul Harmatz, Elisa Leão Teles, Roberto Giugliani, John J. Hopwood, Clara Sá-Miranda, Stuart J. Swiedler, Nathalie Guffon, Michael Beck, Zi‐Fan Yu and Ida Vanessa Döederlein Schwartz and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Human Mutation.

In The Last Decade

David Ketteridge

30 papers receiving 1.1k citations

Peers

Countries citing papers authored by David Ketteridge

Since Specialization

Citations

This map shows the geographic impact of David Ketteridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ketteridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ketteridge more than expected).

Fields of papers citing papers by David Ketteridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ketteridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ketteridge. The network helps show where David Ketteridge may publish in the future.

Co-authorship network of co-authors of David Ketteridge

This figure shows the co-authorship network connecting the top 25 collaborators of David Ketteridge. A scholar is included among the top collaborators of David Ketteridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ketteridge. David Ketteridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Open‐label, single‐center, clinical study evaluating the safety, tolerability and clinical effects of pentosan polysulfate sodium in subjects with mucopolysaccharidosis I	Journal of Inherited Metabolic Disease	Drago Bratkovic, David Ketteridge et al.	0
2	Functional assessment of the genetic findings indicating mucopolysaccharidosis type II in the prenatal setting	JIMD Reports	Maria Fuller, David Ketteridge	2
3	Screening for Carpal Tunnel Syndrome in Patients With Mucopolysaccharidosis	Journal of Child Neurology	Georgia Antoniou, David Ketteridge et al.	8
4	Are conventional stone analysis techniques reliable for the identification of 2,8-dihydroxyadenine kidney stones? A case series	Urolithiasis	Hrafnhildur L. Runolfsdottir, Tzu-Ling Lin et al.	3
5	Tarsal tunnel syndrome in the mucopolysaccharidoses: A case series and literature review	JIMD Reports	Nicole Williams, David Ketteridge et al.	2
6	Neonatal Onset Interstitial Lung Disease as a Primary Presenting Manifestation of Mucopolysaccharidosis Type I	JIMD Reports	Douglas Bush, Jill Lipsett et al.	10
7	Presentation of m.3243A>G (MT‐TL1; tRNALeu) variant with focal neurology in infancy	American Journal of Medical Genetics Part A	Dylan Mordaunt, Liam McIntyre et al.	3
8	Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux–Lamy syndrome)—10‐year follow‐up of patients who previously participated in an MPS VI survey study	American Journal of Medical Genetics Part A	Roberto Giugliani, Christina Lampe et al.	68
9	SURF1 deficiency: a multi-centre natural history study	Orphanet Journal of Rare Diseases	Yehani Wedatilake, Ruth M. Brown et al.	91
10	Expert recommendations for the laboratory diagnosis of MPS VI	Molecular Genetics and Metabolism	Timothy C. Wood, Olaf A. Bodamer et al.	33
11	Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase	Journal of Pediatric Rehabilitation Medicine	Celeste Decker, Zi‐Fan Yu et al.	52
12	An overview of intra-articular therapy for mucopolysaccharidosis VI	Journal of Pediatric Rehabilitation Medicine	Dyane Auclair, David Ketteridge et al.	6
13	Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase	Molecular Genetics and Metabolism	Paul Harmatz, Roberto Giugliani et al.	159
14	Mutational analysis of 105 mucopolysaccharidosis type VI patients	Human Mutation	Litsa Karageorgos, Doug A. Brooks et al.	97
15	610: Dietary L-tyrosine supplementation in nemaline myopathy	Journal of Clinical Neuroscience	Monique M. Ryan, Carolyn Ellaway et al.	2
16	Mutational analysis of mucopolysaccharidosis type VI patients undergoing a phase II trial of enzyme replacement therapy	Molecular Genetics and Metabolism	Litsa Karageorgos, Doug A. Brooks et al.	29
17	Clinical, enzymatic and molecular characterization of nine new patients with malonyl‐coenzyme A decarboxylase deficiency	Journal of Inherited Metabolic Disease	Gajja S. Salomons, C. Jakobs et al.	34
18	Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)	American Journal of Medical Genetics Part A	Stuart J. Swiedler, Michael Beck et al.	117
19	Cannabis cookies: A cause of coma	Journal of Paediatrics and Child Health	C. Boros, David Parsons et al.	31
20	Differentiation of newly isolated strains of Trypanosoma (Schizotrypanum) cruzi by agglutination and precipitation reactions.	Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)	David Ketteridge	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact